4//SEC Filing
Garza Jaime 4
Accession 0001062993-23-015064
CIK 0001842939other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 8:42 PM ET
Size
6.1 KB
Accession
0001062993-23-015064
Insider Transaction Report
Form 4
Garza Jaime
Director
Transactions
- Award
Stock Option (right to buy)
2023-07-14+76,878→ 76,878 totalExercise: $2.11Exp: 2031-09-23→ Common Stock (76,878 underlying)
Footnotes (2)
- [F1]Options to purchase 76,878 shares of common stock of Legacy Carmell (as defined below) granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
- [F2]On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation.
Issuer
ALPHA HEALTHCARE ACQUISITION CORP III
CIK 0001842939
Entity typeother
Related Parties
1- filerCIK 0001984126
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 8:42 PM ET
- Size
- 6.1 KB